Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Galena Biopharma GALE

Healthcare Biotechnology
"Galena Biopharma is a biopharmaceutical company. Its main activity is the development and commercialization of hematology and oncology therapies. Its pipeline includes products targeting hematology diseases, breast cancer, gastric cancer, and gynecological cancer. The company’s cancer immunotherapy consists of two areas: prevention of cancer reoccurrence and primary prevention of invasive... see more

Recent & Breaking News (NDAQ:GALE)

SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Galena Biopharma, Inc. and Encourages Investors With Losses to Contact the Firm

Business Wire March 27, 2017

Lifshitz & Miller LLP Announces Investigation of Air Methods Corporation, Fortress Investment Group LLC, Galena Biopharma, Inc., Ionis Pharmaceuticals, Inc., LMI Aerospace, Inc., Lumos Networks Corp., Silver Bay Realty Trust Corp. and TerraForm Global, In

PR Newswire March 24, 2017

GALE STOCK LOSS: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors of Important Deadline in Class Action – GALE

GlobeNewswire March 17, 2017

Galena Biopharma Presents Positive Final GALE-301 (E39) Phase 1/2a Clinical Trial Data

GlobeNewswire March 17, 2017

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Galena Biopharma, Inc. To Contact The Firm Before Lead Plaintiff Deadline

GlobeNewswire March 15, 2017

Galena Biopharma Reports Fourth Quarter and Year End 2016 Financial Results and Provides a Corporate Update

GlobeNewswire March 15, 2017

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Galena Biopharma, Inc. (GALE) & Lead Plaintiff Deadline: April 14, 2017

GlobeNewswire March 10, 2017

Galena Biopharma Engages Canaccord Genuity to Advise on Strategic Alternatives

GlobeNewswire March 9, 2017

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Galena Biopharma, Inc. (GALE) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

GlobeNewswire March 7, 2017

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Galena Biopharma, Inc. – GALE

GlobeNewswire March 3, 2017

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Galena Biopharma, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

Business Wire February 26, 2017

IMPORTANT GALENA BIOPHARMA, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the District of New Jersey against Galena Biopharma, Inc.

GlobeNewswire February 24, 2017

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Galena Biopharma Inc., and Encourages Investors with Losses to Contact the Firm

Business Wire February 22, 2017

Investor Alert: Kaplan Fox Announces Investigation Of Galena Biopharma Inc.

PR Newswire February 22, 2017

Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim Chief Executive Officer

GlobeNewswire February 21, 2017

Biotech Stocks under Scanner -- ACADIA Pharma, Clovis Oncology, Galena Biopharma, and Northwest Biotherapeutics

PR Newswire February 21, 2017

GALE FRAUD NOTICE: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors of Important Deadline in Class Action – GALE

Business Wire February 20, 2017

INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire February 16, 2017

The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Galena Biopharma, Inc. Investors and Encourages Investors to Contact the Firm

Business Wire February 16, 2017

INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire February 16, 2017